مساعد بن عبدالله الخليف

=
 
 
 
 

Summary:
Musaed Alkholief earned his Ph.D. in May 2015 from Massachusetts College of Pharmacy and Health Sciences University, USA. Following his return to Saudi Arabia, he was appointed as an Assistant Professor in the Department of Pharmaceutics, College of Pharmacy, King Saud University. Since then, he has been involved in teaching multiple courses for undergrad and grad students, while carrying out research in multiple areas, including his area of interest, cancer drug delivery and drug targeting. On the administrative level, Dr. Alkholief was actively involved early on in many committees and councils in the College of Pharmacy, which has lead King Saud University to appoint him as the Assistant Vice-Rector for Planning and Development in February 2017, besides his aforementioned academic and research activities.
 

Academic Degrees:

• 2010 – 2015

Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences University, Boston, MA, USA.
 

• 2002 – 2008

Bachelor of Pharmaceutical Sciences, King Saud University, Riyadh, Saudi Arabia
 
Academic Positions:

• Jul 2015 – to date

Assistant Professor at the Department of Pharmaceutics, King Saud University, Riyadh, Saudi Arabia.
 

• Jul 2010 – May 2015

Teaching Assistant at Department of Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences University, Worcester, Massachusetts, USA.
 

• Jul 2008 – Aug 2009

Teaching Assistant at the Department of Pharmaceutics, King Saud University, Riyadh, Saudi Arabia.
 
Continuing Professional Education and Development:
- Antibodies: Sequence, Structure and Designing Therapeutics (University College London).
- Preparation for PMP exam (PMI and King Saud University).
- Project management professional PMP program (PMI and King Saud University).
- First Saudi Drug Quality Symposium (Alfaisal University and Novartis).
- Essentials for Effective Peer Review of Teaching (King Saud University).
- Fundamentals of Student Assessment system (King Saud University).
- Biosafety and Bloodborne Pathogen Refresher for Laboratory Personnel (Northeastern University).
- Radiation Safety Initial Worker Online Training (Northeastern University).
- Chemical Hygiene Training - Lab Safety and Hazardous Waste Management (MCPHS University).
 
Courses Taught:
- PHT 210: Pharmaceutical Calculations (PharmD program).
- PHT 414: Biopharmaceutics (B. Pharm program).
- PHT 417: Biopharmaceutics and Pharmacokinetics (PharmD program).
- PHT 426: Pharmaceutical Biotechnology (PharmD program).
- PHT 539: Advanced Biopharmaceutics (MS. program).
- PHT 612: Selected Topics in Drug Delivery I (PhD program).
- PHT 624: Selected Topics in Drug Delivery II (PhD program).
 

• Invitations

 
- Speaker: Applications of Nanotechnology in Cancer, King Abdullah Institute for Nanotechnology – Nano Club and King Saud University, 2017.
 

 
 
Administrative Positions:

•  Feb 2017 – to date

Assistant Vice-Rector for Planning and Development, King Saud University, Riyadh, Saudi Arabia.
As the Vice-Rectorate for Planning and development is the head of key units in planning-quality-information, responsibilities include, but not limited to:

• Offering guidance on institutional leadership in all planning-quality-information matters, creating services, and supporting value to all academic and administrative units institution-wide.
•  Providing direct oversight on all policy matters and supervising the planning-quality-information functional areas within its institutional jurisdiction to key operational units under the direct supervision of the vice-rectorate.
• Ensuring efficient and effective performance monitoring, measurement and management of the main planning-quality-information functional areas as planned, executed and managed for performance on the ITQAN 2020 system platform by the units under the vice-rectorate supervision.

Councils and Committees membership:
- Health colleges students’ interview committee, King Saud University (July 2017).
- King Saud University representative in deliberating the Saudi Arabian Qualifications’ Framework Project with the Education Excellence Commission (Apr 2017 – to date).
-Vice-rectorate for planning and development representative in King Saud University’s committee for the preparation of administrative policies and procedures manual (Mar 2017 – to date).
- Pharmacy College Council, College of Pharmacy, King Saud University (Dec 2016 – to date).
- Pharmaceutics Department Council, College of Pharmacy, King Saud University (July 2016 – to date).
- Assessment Committee, College of Pharmacy, King Saud University (Sep 2015 – Feb 2017)
- Pharmacy Education Unit Committee, College of Pharmacy, King Saud University (Dec 2015 – Feb 2017)
- Exams Committee, College of Pharmacy, King Saud University, (Sep 2015 – Sep 2016)
- Pharmaceutics department representative in quality and accreditation committee. College of Pharmacy, King Saud University (Sep 2015 – Feb 2017).
- Pharmaceutics Department Employment and Human Resources committee, College of Pharmacy, King Saud University (Sep 2015 – to date).
- Pharmaceutics department Graduate Program Research Proposal Investigation committee, College of Pharmacy, King Saud University (Sep 2015 – to date).       

Positions:

• Sep 2017 – to date

Director of the Nanomedicine Research Unit, College of Pharmacy, King Saud University.
 

• May 2016 – Sep 2017

Deputy Director of the Nanomedicine Research Unit, College of Pharmacy, King Saud University.
 

• Apr 2016 – to date

Associate Editor, Saudi Pharmaceutical Journal, Saudi Arabia.
 
 
Publications and Abstracts:

• Safety and efficacy of Ceftolozane/tazobactam for the Treatment of Multi-Drug- Resistant Pseudomonas aeruginosa Pneumonia in a Hemodialysis Patient. Mohammed Alessa, Thamer Almangour, Abdulaziz Alhossan, Musaed Alkholief, and DeanneTabb. (Accepted)

• Sultan Alshehri, Faiyaz Shakeel, Ph.D.; Mohamed Ibrahim, Ph.D.; Ehab Elzayat, Ph.D.; Mohammad Altamimi, Ph.D.; Gamal Shazly, Ph.D.; Kazi Mohsin, Ph.D.; Musaed Alkholief, Ph.D.; Bader Alsulays, Ph.D.; Abdullah Alshetaili, Ph.D.; Abdulaziz Alshahrani, M. Pharm.; Bander  Almalki, Ph.D.; Fars K Alanazi, Ph.D. Influence of the microwave technology on solid dispersions of mefenamic acid and flufenamic acid. (Accepted)

• Talal Nahar-Alshammari, Mohd Abul Kalam, Musaed Alkholief and Aws Alshamsan. Development and characterization of liposomal delivery system of Metformin and Reserpine. 7th College of Pharmacy Research Day (7th CPRD), 2017.

• Shweta A. Raina, Aalok Shah, Xin Wang, Musaed Alkholief, Samuel Gatley, Kai-Tak Wan,  and Robert B. Campbell. Characterizing functional properties of mucin glycosylation: Differential cytotoxicity, intracellular drug uptake, and mechanical forces delaying drug entry. (submitted)

• Alkholief, M. and R. B. Campbell "Investigating the role of mucin in the delivery of nanoparticles to cellular models of human cancer disease: an in vitro study." Nanomedicine: Nanotechnology, Biology and Medicine. Volume 12, Issue 5, 1291 - 1302.

• Alkholief M, Campbell R. An Evaluation of the Role of Mucin in Nano Drug Delivery II. First Joint NanoWorcester/AVS-New England Spring meeting at WPI. Worcester, MA 2015.

• Shaohua Cheng, William Crall, Bryan Nguyen, Charles Dang, Musaed Alkholief, Robert Campbell. Development of Ceramide Liposomes for Tumor Interstitial and Vascular Drug Targeting. American Association of Cancer Research (AACR) annual meeting. San Diego, CA 2014.

• Acheampong S, Dang C, Huynh H, Nguyen R, Truong P, Alkholief M, Campbell R Analysis of Cationic Ceramide Liposomes in Anticancer Drug Therapy: An in vitro study. Second Annual SOP-W/M Research Day. Worcester, MA 2013

• Alkholief M, Campbell R. An Evaluation of the Role of Mucin in Nano Drug Delivery I. American Association of Cancer Research (AACR) annual meeting. Washington, DC 2013.

• Alkholief M, Djazayeri S, Price K, Campbell R. An Evaluation of Mucin Expression in Cancerous Tissues. First Annual SOP-W/M Research Day. Worcester, MA 2012

• Alkholief M, Abdulghani A, Zeineldin R. Intracellular fate of carbon nanotubes targeting specific receptors on ovarian cancer cells. Nano in Cancer – American Association of Cancer Research (AACR) special conference. Miami, FL 2011